What We're Reading: Page 222
Industry reads hand-picked by our editors
Apr 26, 2019
Apr 25, 2019
-
Los Angeles Times
Robotic device winds its own way through a beating pig heart
-
National Geographic
New device translates brain activity into speech. Here’s how.
-
STAT News
FDA hires Pew director to lead regulatory policy
-
RAPS
Digital Health: ‘Connecting the Dots’ Across FDA Centers
-
Macworld
Google Fit arrives on iOS, but Wear OS smartwatches and Apple Health still won't play nice
Apr 24, 2019
-
STAT News
A machine learning device, meant to monitor the chronically ill, moves into homes
-
Associated Press
Hospitals sue over new national liver transplant policy
-
MobiHealthNews
Oscar Health inks deal with Cardiogram to give members health detection technology
-
BioPharma Dive
In a first, pharma distributor and execs face criminal charges for role in opioid crisis
Apr 23, 2019
-
The Washington Post
Smoking and depression apps are selling your data to Google and Facebook, study finds
-
NPR
Google Searches For Ways To Put Artificial Intelligence To Use In Health Care
-
The New York Times
The Military Wants Better Tests for PTSD. Speech Analysis Could Be the Answer.
-
The Wall Street Journal
Elizabeth Holmes Gets Delay in Trial-Date Decision
Apr 22, 2019
-
Minneapolis Star Tribune
UnitedHealth grows digital health business in Minneapolis
-
The Atlantic
The Helmet That ‘Resets’ Your Brain
-
The New York Times
The Search for a Biomarker for Early Autism Diagnosis
-
Bloomberg
Ancestry Is Said to Prepare for IPO as DNA-Test Industry Booms
Apr 18, 2019
-
Forbes
Avalere Founder Dan Mendelson on TAVR: Bringing Real Innovation To Medicare
-
Medical Design & Outsourcing
Medline Industries buys Namic business from AngioDynamics
-
RAPS
MedTech Europe Warns Over ‘Untenable’ Transition to EU MDR/IVDR
-
The New York Times
How a Chicago Woman Fell Victim to Candida Auris, a Drug-Resistant Fungus
Apr 17, 2019
-
RAPS
Experts Tell Device Companies Not to Fret Over QMS Transition
-
GenomeWeb
Inova Decides to End PGx Test Offerings in Response to FDA Warning Letter
-
360Dx
Thermo Fisher, NX Prenatal Partner on Pregnancy Outcome Assay Development
-
The Wall Street Journal
A Powerful Lobbying Tool in the Trump Era: the President’s Ear
Previous
